The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Olaparib is indicated for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to chemotherapy
Roche will unveil the primary results from the phase III evERA Breast Cancer study evaluating giredestrant
Subscribe To Our Newsletter & Stay Updated
